Andere Sprachen Chimerix, Inc.

Aktien

A1T65B

US16934W1062

CMRX

Biotechnologie

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 04.12.2024			% 5 Tage	% 1. Jan.
0,8699 ^USD	+1,12 %		-3,88 %	-9,62 %

07.11.	Chimerix, Inc., Q3 2024 Earnings Call, Nov 07, 2024
07.11.	Chimerix, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2024	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting	11.11.
Earnings Flash (CMRX) CHIMERIX Posts Q3 Revenue $26,000	07.11.
Chimerix: Q3 Earnings Snapshot	07.11.
Chimerix : Reports Third Quarter 2024 Financial Results and Provides Operational Update Form 8 K	07.11.
Chimerix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	07.11.
Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update	07.11.
Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024	04.11.
Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024	01.11.
Chimerix Reports Inducement Grant under Nasdaq Listing Rule 5635(4)	21.10.
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	18.10.
Chimerix, Inc.(NasdaqGM:CMRX) dropped from S&P Global BMI Index	23.09.
Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference	03.09.
Chimerix Reports Inducement Grant under Nasdaq Listing Rule 5635(4)	02.09.
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	30.08.
Chimerix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	13.08.
Chimerix: Q2 Earnings Snapshot	13.08.
Earnings Flash (CMRX) CHIMERIX Posts Q2 Revenue $129,000, vs. Street Est of $260,000	13.08.
Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update	13.08.
Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024	06.08.
Chimerix Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	08.07.
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05.07.
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference	30.05.
Chimerix : Corporate Presentation	03.05.
Chimerix: Q1 Earnings Snapshot	01.05.
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update	01.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Chimerix, Inc.

Aktien

A1T65B

US16934W1062

CMRX

Biotechnologie

Andere Sprachen

Filter